Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells

Withdrawn

• Conditions: Chronic Hepatitis C

• Registration Number: NCT02545387
• Lead Sponsor: Medical University of Graz

Brief Summary

Patients with hepatitis C show impaired neutrophil function. It is not known whether this is a direct of an indirect phenomenon. Using bone marrow biopsies from patients with hepatitis C it is possible to see whether neutrophil granulocyte progenitors are already infected with hepatitis C.

Detailed Description

Neutrophil granulocytes are important components of the innate immune system and pioneers in the fight against both fungal and bacterial infections. If pathogens enter the body, they are marked as foreign by antibodies and the complement system. Afterwards receptors on the neutrophils recognize and bind on these foreign substances to make them harmless. This process is called phagocytosis. Hepatitis C virus (HCV) and neutrophils are rarely associated. The HCV belongs to the Flaviviridae. It is a single-stranded, enveloped RNA virus with a positive polarity, which cause chronic hepatitis C (CHC) in approximately 170 million people worldwide. Subsequently, such an infection leads to liver cirrhosis and carcinoma in a significant proportion of patients. The virus infects mainly hepatocytes, but extrahepatic replication has also been shown. HCV usually enters the cell through receptor-mediated endocytosis (claudin-1, cluster of differentiation (CD)81, occludin and scavenger receptor 1), before it abuses the cell's own infrastructure for the viral protein synthesis.

The aim of this study is to determine neutrophil function in chronic hepatitis C infected patients. Furthermore the investigators want to examine if neutrophils or their precursor cells are infected with HCV and if this leads to their dysfunction.

Study Timeline

• Study Start: 2015-01
• Study First Submitted: 2015-07-29
• Study First Submitted QC: 2015-09-07
• Study First Posted: 2015-09-10
• Status Verified: 2018-12
• Primary Completion: 2018-12
• Study Completion: 2018-12
• Last Update Submitted: 2018-12-14
• Last Update Posted: 2018-12-19

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• chronic hepatitis C
• Genotype 1-4

Exclusion Criteria

• acute hepatitis C

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
viral RNA	day 1	hepatitis C virus RNA

Secondary Outcome Measures

Name	Time	Method
hepatitis C virus proteins	day 1	presence of hepatitis C virus proteins in neutrophils
neutrophil phagocytic capacity	day 1	function of neutrophil granulocytes in hepatitis C patients

Trial Locations

Locations (1)

Department of Internal Medicine, Medical University of Graz; 🇦🇹 Graz, Austria